Search
for
Sort by
Research 121–150 of 1000+
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Non-Scarring Alopecia in Females: A Comprehensive Review
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Meeting Report: 68th Montagna Symposium on the Biology of Skin “Decoding Complex Skin Diseases: Integrating Genetics, Genomics, and Disease Biology”
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Recent advances in glycopeptide hydrogels: design, biological functions, and biomedical applications
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- POSTĘP W DIAGNOZIE I LECZENIU STWARDNIENIA ROZSIANEGO
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Poster Presentations
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Head and Neck 3D Bioprinting—A Review on Recent Advancements in Soft Tissue 3D Bioprinting and Medical Applications
- Multi-omics and AI-driven advances in miRNA-mediated hair follicle regulation in cashmere goats
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- Regenerative Strategies for Androgenetic Alopecia: Evidence, Mechanisms, and Translational Pathways
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach